Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A. Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC Cardiovasc Interv. 2015;8:1445–53. https://doi.org/10.1016/j.jcin.2015.06.017.

Article  PubMed  Google Scholar 

von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, Sharaf BL, et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the national heart, lung, and blood institute-sponsored women’s ischemia syndrome evaluation (WISE). Circulation. 2004;109:722–5. https://doi.org/10.1161/01.CIR.0000115525.92645.16.

Article  Google Scholar 

Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518–27. https://doi.org/10.1161/CIRCULATIONAHA.113.008507.

Article  PubMed  PubMed Central  Google Scholar 

Schroder J, Michelsen MM, Mygind ND, Suhrs HE, Bove KB, Bechsgaard DF, et al. Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study. Eur Heart J. 2021;42:228–39. https://doi.org/10.1093/eurheartj/ehaa944.

Article  PubMed  CAS  Google Scholar 

Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas AHEM, et al. An EAPCI Expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group. EuroIntervention. 2021;16:1049–69. https://doi.org/10.4244/EIJY20M07_01.

Article  PubMed  PubMed Central  Google Scholar 

Marinescu MA, Löffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM. Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging. 2015;8:210–20. https://doi.org/10.1016/j.jcmg.2014.12.008.

Article  PubMed  PubMed Central  Google Scholar 

Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol. 2018;72:2625–41. https://doi.org/10.1016/j.jacc.2018.09.042.

Article  PubMed  PubMed Central  Google Scholar 

Gdowski MA, Murthy VL, Doering M, Monroy-Gonzalez AG, Slart R, Brown DL. Association of isolated coronary microvascular dysfunction with mortality and major adverse cardiac events: a systematic review and meta-analysis of aggregate data. J Am Heart Assoc. 2020;9: e014954. https://doi.org/10.1161/JAHA.119.014954.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, et al. Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841–2. https://doi.org/10.1161/01.cir.93.5.841.

Article  PubMed  CAS  Google Scholar 

Maron BJ, Wolfson JK, Ciró E, Spirito P. Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol. 1983;51:189–94. https://doi.org/10.1016/s0002-9149(83)80034-4.

Article  PubMed  CAS  Google Scholar 

Suzuki Y, Kadota K, Nohara R, Tamaki S, Kambara H, Yoshida A, et al. Recognition of regional hypertrophy in hypertrophic cardiomyopathy using thallium-201 emission-computed tomography: comparison with two-dimensional echocardiography. Am J Cardiol. 1984;53:1095–102. https://doi.org/10.1016/0002-9149(84)90644-1.

Article  PubMed  CAS  Google Scholar 

Mochizuki T, Murase K, Fujiwara Y, Tanada S, Hamamoto K, Tauxe WN. Assessment of systolic thickening with thallium-201 ECG-gated single-photon emission computed tomography: a parameter for local left ventricular function. J Nucl Med. 1991;32:1496–500.

PubMed  CAS  Google Scholar 

Cannon RO 3rd, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation. 1985;71:234–43. https://doi.org/10.1161/01.cir.71.2.234.

Article  PubMed  Google Scholar 

Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (‘small vessel’) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545–57. https://doi.org/10.1016/s0735-1097(86)80181-4.

Article  PubMed  CAS  Google Scholar 

Shinohara H, Fukuda N, Soeki T, Tanaka H, Bando K, Tamura Y. Clinical significance of coronary flow reserve in hypertrophied heart: comparison with Doppler index, hemodynamics and plasma natriuretic peptide concentrations. J Cardiol. 2001;37:19–25.

PubMed  CAS  Google Scholar 

Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027–35. https://doi.org/10.1056/NEJMoa025050.

Article  PubMed  CAS  Google Scholar 

Garcia Brás P, Aguiar Rosa S, Thomas B, Fiarresga A, Cardoso I, Pereira R, et al. Associations between perfusion defects, tissue changes and myocardial deformation in hypertrophic cardiomyopathy, uncovered by a cardiac magnetic resonance segmental analysis. Rev Port Cardiol. 2022;41:559–68. https://doi.org/10.1016/j.repc.2022.03.003.

Article  PubMed  Google Scholar 

Tian H, Yang C, Song Y, Wang H, Yuan J, Cui J, et al. Microvascular rarefaction and myocardial fibrosis in hypertrophic obstructive cardiomyopathy. Cardiology. 2018;141:202–11. https://doi.org/10.1159/000493005.

Article  PubMed  Google Scholar 

Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the american college of cardiology foundation/american heart association task force on practice guidelines. developed in collaboration with the american association for thoracic surgery, american society of echocardiography, american society of nuclear cardiology, heart failure society of america, heart rhythm society, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol. 2011;58:e212–60. https://doi.org/10.1016/j.jacc.2011.06.01.1.

Article  PubMed  CAS  Google Scholar 

Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Authors/Task Force members, et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79. https://doi.org/10.1093/eurheartj/ehu284.

Article  PubMed  Google Scholar 

Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, et al. JCS/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies. Circ J. 2021;85:1590–689. https://doi.org/10.1253/circj.CJ-20-0910.

Article  PubMed  Google Scholar 

Ford TJ, Berry C. How to diagnose and manage angina without obstructive coronary artery disease: lessons from the British Heart Foundation CorMicA trial. Interv Cardiol. 2019;14:76–82. https://doi.org/10.15420/icr.2019.04.R1.

Article  PubMed  PubMed Central  Google Scholar 

Ford TJ, Stanley B, Sidik N, Good R, Rocchiccioli P, McEntegart M, et al. 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). JACC Cardiovasc Interv. 2020;13:33–45. https://doi.org/10.1016/j.jcin.2019.11.001.

Article  PubMed  PubMed Central  Google Scholar 

Ford TJ, Stanley B, Good R, Rocchiccioli P, McEntegart M, Watkins S, et al. Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol. 2018;72:2841–55. https://doi.org/10.1016/j.jacc.2018.09.006.

Article  PubMed  Google Scholar 

Olivotto I, Girolami F, Sciagrà R, Ackerman MJ, Sotgia B, Bos JM, et al. Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations. J Am Coll Cardiol. 2011;58:839–48. https://doi.org/10.1016/j.jacc.2011.05.018.

Article  PubMed  Google Scholar 

Knaapen P, Germans T, Camici PG, Rimoldi OE, ten Cate FJ, ten Berg JM, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008;294:H986–93. https://doi.org/10.1152/ajpheart.00233.2007.

Article  PubMed  CAS  Google Scholar 

de Bruyne B, Bartunek J, Sys SU, Pijls NH, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans. Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation. 1996;94:1842–9. https://doi.org/10.1161/01.cir.94.8.1842.

Article  PubMed  Google Scholar 

Claeys MJ, Vrints CJ, Bosmans J, Krug B, Blockx PP, Snoeck JP. Coronary flow reserve during coronary angioplasty in patients with a recent myocardial infarction: relation to stenosis and myocardial viabilit